“…In the area of drug discovery, active learning has been shown to efficiently derive high-performance prediction models based on small subsets of input data [32,34,39,46]. Furthermore, actively trained models not only reached significantly higher hit rates compared to experimental standards which frequently remain below 1 % in cases of unbiased chemical libraries [34,39,40,[47][48][49], but such models also contributed to successful identification of novel bioactive compounds [33,36,42] and cancer rescue mutants of p53 [31].…”